5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review

Andrea Avendaño, Irene Paradisi, Francisco Cammarata-Scalisi, Michele Callea

Research output: Contribution to journalReview article

Abstract

5-α-Reductase type 2 enzyme catalyzes the conversion of testosterone into dihydrotestosterone, a potent androgen responsible for male sexual development during the fetal period and later during puberty. Its deficiency causes an autosomal recessive disorder of sex development characterized by a wide range of under-virilization of external genitalia in patients with a 46,XY karyotype. Mutations in the SRD5A2 gene cause 5-α-Reductase deficiency; although it is an infrequent disorder, it has been reported worldwide, with mutational heterogeneity. Furthermore, it has been proposed that there is no genotype-phenotype correlation, even in patients carrying the same mutation. The aim of this review was to perform an extensive search in various databases and to select those articles with a comprehensive genotype and phenotype description of the patients, classifying their phenotypes using the external masculinization score (EMS). Thus, it was possible to objectively compare the eventual genotype-phenotype correlation between them. The analysis showed that for most of the studied mutations no correlation can be established, although the specific location of the mutation in the protein has an effect on the severity of the phenotype. Nevertheless, even in patients carrying the same homozygous mutation, a variable phenotype was observed, suggesting that additional genetic factors might be influencing it. Due to the clinical variability of the disorder, an accurate diagnosis and adequate medical management might be difficult to carry out, as is highlighted in the review.

Original languageEnglish
Pages (from-to)197-204
Number of pages8
JournalHormones
Volume17
Issue number2
DOIs
Publication statusPublished - Jun 2018

Fingerprint

Genetic Association Studies
Oxidoreductases
Mutation
Phenotype
Virilism
Disorders of Sex Development
Sexual Development
Genitalia
Dihydrotestosterone
Puberty
Karyotype
Androgens
Testosterone
Genotype
Databases
Enzymes
Genes
Proteins

Keywords

  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/blood
  • 46, XY Disorders of Sex Development/blood
  • Genitalia/abnormalities
  • Genotype
  • Humans
  • Hypospadias/blood
  • Phenotype
  • Steroid Metabolism, Inborn Errors/blood

Cite this

5-α-Reductase type 2 deficiency : is there a genotype-phenotype correlation? A review. / Avendaño, Andrea; Paradisi, Irene; Cammarata-Scalisi, Francisco; Callea, Michele.

In: Hormones, Vol. 17, No. 2, 06.2018, p. 197-204.

Research output: Contribution to journalReview article

Avendaño, Andrea ; Paradisi, Irene ; Cammarata-Scalisi, Francisco ; Callea, Michele. / 5-α-Reductase type 2 deficiency : is there a genotype-phenotype correlation? A review. In: Hormones. 2018 ; Vol. 17, No. 2. pp. 197-204.
@article{80e48eb885f84195a1e291ed64ff220e,
title = "5-α-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review",
abstract = "5-α-Reductase type 2 enzyme catalyzes the conversion of testosterone into dihydrotestosterone, a potent androgen responsible for male sexual development during the fetal period and later during puberty. Its deficiency causes an autosomal recessive disorder of sex development characterized by a wide range of under-virilization of external genitalia in patients with a 46,XY karyotype. Mutations in the SRD5A2 gene cause 5-α-Reductase deficiency; although it is an infrequent disorder, it has been reported worldwide, with mutational heterogeneity. Furthermore, it has been proposed that there is no genotype-phenotype correlation, even in patients carrying the same mutation. The aim of this review was to perform an extensive search in various databases and to select those articles with a comprehensive genotype and phenotype description of the patients, classifying their phenotypes using the external masculinization score (EMS). Thus, it was possible to objectively compare the eventual genotype-phenotype correlation between them. The analysis showed that for most of the studied mutations no correlation can be established, although the specific location of the mutation in the protein has an effect on the severity of the phenotype. Nevertheless, even in patients carrying the same homozygous mutation, a variable phenotype was observed, suggesting that additional genetic factors might be influencing it. Due to the clinical variability of the disorder, an accurate diagnosis and adequate medical management might be difficult to carry out, as is highlighted in the review.",
keywords = "3-Oxo-5-alpha-Steroid 4-Dehydrogenase/blood, 46, XY Disorders of Sex Development/blood, Genitalia/abnormalities, Genotype, Humans, Hypospadias/blood, Phenotype, Steroid Metabolism, Inborn Errors/blood",
author = "Andrea Avenda{\~n}o and Irene Paradisi and Francisco Cammarata-Scalisi and Michele Callea",
year = "2018",
month = "6",
doi = "10.1007/s42000-018-0013-9",
language = "English",
volume = "17",
pages = "197--204",
journal = "Hormones",
issn = "1109-3099",
publisher = "Hellenic Endocrine Society",
number = "2",

}

TY - JOUR

T1 - 5-α-Reductase type 2 deficiency

T2 - is there a genotype-phenotype correlation? A review

AU - Avendaño, Andrea

AU - Paradisi, Irene

AU - Cammarata-Scalisi, Francisco

AU - Callea, Michele

PY - 2018/6

Y1 - 2018/6

N2 - 5-α-Reductase type 2 enzyme catalyzes the conversion of testosterone into dihydrotestosterone, a potent androgen responsible for male sexual development during the fetal period and later during puberty. Its deficiency causes an autosomal recessive disorder of sex development characterized by a wide range of under-virilization of external genitalia in patients with a 46,XY karyotype. Mutations in the SRD5A2 gene cause 5-α-Reductase deficiency; although it is an infrequent disorder, it has been reported worldwide, with mutational heterogeneity. Furthermore, it has been proposed that there is no genotype-phenotype correlation, even in patients carrying the same mutation. The aim of this review was to perform an extensive search in various databases and to select those articles with a comprehensive genotype and phenotype description of the patients, classifying their phenotypes using the external masculinization score (EMS). Thus, it was possible to objectively compare the eventual genotype-phenotype correlation between them. The analysis showed that for most of the studied mutations no correlation can be established, although the specific location of the mutation in the protein has an effect on the severity of the phenotype. Nevertheless, even in patients carrying the same homozygous mutation, a variable phenotype was observed, suggesting that additional genetic factors might be influencing it. Due to the clinical variability of the disorder, an accurate diagnosis and adequate medical management might be difficult to carry out, as is highlighted in the review.

AB - 5-α-Reductase type 2 enzyme catalyzes the conversion of testosterone into dihydrotestosterone, a potent androgen responsible for male sexual development during the fetal period and later during puberty. Its deficiency causes an autosomal recessive disorder of sex development characterized by a wide range of under-virilization of external genitalia in patients with a 46,XY karyotype. Mutations in the SRD5A2 gene cause 5-α-Reductase deficiency; although it is an infrequent disorder, it has been reported worldwide, with mutational heterogeneity. Furthermore, it has been proposed that there is no genotype-phenotype correlation, even in patients carrying the same mutation. The aim of this review was to perform an extensive search in various databases and to select those articles with a comprehensive genotype and phenotype description of the patients, classifying their phenotypes using the external masculinization score (EMS). Thus, it was possible to objectively compare the eventual genotype-phenotype correlation between them. The analysis showed that for most of the studied mutations no correlation can be established, although the specific location of the mutation in the protein has an effect on the severity of the phenotype. Nevertheless, even in patients carrying the same homozygous mutation, a variable phenotype was observed, suggesting that additional genetic factors might be influencing it. Due to the clinical variability of the disorder, an accurate diagnosis and adequate medical management might be difficult to carry out, as is highlighted in the review.

KW - 3-Oxo-5-alpha-Steroid 4-Dehydrogenase/blood

KW - 46, XY Disorders of Sex Development/blood

KW - Genitalia/abnormalities

KW - Genotype

KW - Humans

KW - Hypospadias/blood

KW - Phenotype

KW - Steroid Metabolism, Inborn Errors/blood

U2 - 10.1007/s42000-018-0013-9

DO - 10.1007/s42000-018-0013-9

M3 - Review article

C2 - 29858846

VL - 17

SP - 197

EP - 204

JO - Hormones

JF - Hormones

SN - 1109-3099

IS - 2

ER -